Abstract
Pharmacological and non-pharmacological treatments and outcomes for new-onset atrial fibrillation in ICU patients: the CAFE scoping review and database analyses.
Highlights
New-onset atrial fibrillation occurs in around 10% of adults treated in an intensive care unit
Given that readmission with heart failure and thromboembolism increases following an episode of new-onset atrial fibrillation while in an intensive care unit, a prospective cohort study to demonstrate the incidence of atrial fibrillation and/or left ventricular dysfunction at hospital discharge and at 3 months following the development of new-onset atrial fibrillation should be undertaken
Our research shows that some new-onset atrial fibrillation treatments work better than others
Summary
New-onset atrial fibrillation occurs in around 10% of adults treated in an intensive care unit. Current practice guidance is based on patients outside the intensive care unit; new-onset atrial fibrillation that develops while in an intensive care unit differs in its causes and the risks and clinical effectiveness of treatments. The lack of evidence on new-onset atrial fibrillation treatment or long-term outcomes in intensive care units means that practice varies. We do not know how new-onset atrial fibrillation in patients treated in an intensive care unit affects heart rate and blood pressure, what the best treatments are or how treatments affect how people recover. New-onset atrial fibrillation (NOAF) is defined as atrial fibrillation (AF) that occurs in a patient with no known history of chronic or paroxysmal AF.[1] It is a common arrhythmia in critically ill patients.[2] It occurs in 5–15% of all patients admitted to a general intensive care unit (ICU),[3,4] rising to 23% of patients with septic shock.[5]. This helped us to understand how to clearly communicate our findings
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
